Cystic Fibrosis Therapeutics Market Size is projected to reach USD 13.88 billion in 2030, growing at a CAGR of 9.12%: Straits Research New York, United States, March 14, 2023 (GLOBE NEWSWIRE) -- Cystic fibrosis is a genetic condition that mostly impacts the lungs but can also impact other organs and systems in the body such as the...

Corbus Pharmaceuticals Announces Phase 2b Study of Lenabasum for Treatment of Cystic Fibrosis Did Not Meet Primary Endpoint Study did not meet primary endpoint of reducing rate of pulmonary exacerbationsLenabasum treatment had a favorable safety profile and was well-toleratedData to be presented at the upcoming North...